摘要
目的:对3种不同抗生素方案治疗支气管肺炎婴幼儿的成本与可行性进行前瞻性研究。方法:2013-04-2014-09我院收治96例支气管肺炎患儿,将其随机分为A组(头孢曲松钠治疗)、B组(头孢他啶治疗)及C组(头孢噻肟钠治疗),3组各32例,比较3组的疗效、不良反应、治疗成本及成本/效果(C/E)。结果:A、B、C3组的总有效率分别为87.5%、90.6%、84,4%,组间比较差异无统计学意义,A、B、C 3组的C/E依次为1.9、2.6、1.6,组间比较差异有统计学意义(P<0.05)。结论:头孢他啶治疗支气管肺炎婴幼儿患者的疗效显著,且经济成本较低,相较于头孢曲松钠与头孢噻肟钠具有更高的临床推广意义。
Objective：The cost and feasibility of three kinds of antibiotic regimens for the treatment of bronchial pneumonia in infants Method：96cases of bronchial pneumonia children admitted in our hospital from Apr 2013 to Sep 2014 were randomly divided into group A（ceftriaxone therapy）,group B（ceftazidime therapy）and group C（sodium cefotaxime therapy）.There were 32 cases in each group.The efficacy of different treatment,adverse reactions,treatment costs and cost/effectiveness（C/E）were compared between the three groups.Result：The total efficiency of group A,B and C was 87.5%,90.6% and 84,4% respectively.There was no significant difference between the three groups.The C/E of group A,B,C was 1.9,2.6and 1.6respectively.There were significant differences between the two groups（P〈0.05）.Conclusion：The treatment efficacy of ceftazidime was significant for infants with bronchial pneumonia,with low economic cost.
出处
《临床急诊杂志》
CAS
2015年第6期449-450,453,共3页
Journal of Clinical Emergency
关键词
支气管肺炎
婴幼儿
抗生素
经济性
疗效
bronchial pneumonia
infant
antibiotics
economy
efficacy
